Toggle navigation
linkedin
Twitter
Patients & Caregivers
Our Commitment
Investigational Medicines
Clinical Trials
IDH Mutations in Cancer
Pyruvate Kinase Deficiency
Patient Resources
Our Medicines
Medical Professionals
Careers
Our Values
Inside Agios
Find a Job
Benefits
Commitment to Our Community
Partnering
Investors
About Us
Mission & Vision
Our Values
Leadership
Board of Directors
Scientific Advisors
Founders
Our History
Corporate Responsibility & Sustainability
Research
Our Research Platform
Cancer Metabolism
Rare Genetic Diseases
Metabolic Immuno-Oncology
Publications
Pipeline
Pipeline Overview
Clinical Programs
Preclinical Programs
Our Medicines
News & Events
Press Releases
Events & Webcasts
Contact Us
News & Insights
IDHIFA® (enasidenib) Receives 2018 Prix Galien Award for Best Pharmaceutical Product
By
10/27/2018
Back